Tedla N, Palladinetti P, Wakefield D, Lloyd A
The Inflammation Research Unit, School of Pathology, University of New South Wales, Australia.
Cytokine. 1999 Jul;11(7):531-40. doi: 10.1006/cyto.1998.0439.
Lymph nodes can be the primary target of infection or malignant transformation and may exhibit characteristic patterns of leukocyte infiltration analogous to those seen in inflammation of other tissues. Leukocyte migration to lymph nodes in vivo is a highly regulated, multi-step process that depends upon adhesion molecules and as yet, uncharacterized chemotactic signals. Chemokines are a key part of the orchestrated code of signals that directs leukocyte subsets to sites of inflammation or immune response. The potential role of these chemoattractants in selective trafficking of leukocyte subsets into lymph nodes was assessed by determining the expression of chemokines on a range of pathological and normal human lymph nodes and by evaluating the cellular composition of each lymph node. In situ hybridization using chemokine riboprobes and immunohistochemistry using specific antibodies were performed in order to correlate the mRNA and protein expression of the chemokines. The cellular source(s) of each chemokine was assessed by immunohistochemical staining of adjacent sections using antibodies directed against distinctive cellular markers. Substantial, but varied, expression of macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, RANTES, macrophage chemotactic protein (MCP)-1, eotaxin, and interleukin 8 (IL-8) were detected in the pathological lymph nodes by diverse cell types. Control lymph nodes showed expression only of RANTES, mainly by high endothelial venules. In all lymph nodes, except the nodes infiltrated with breast cancer, chemokine mRNA expression was highly concordant with the corresponding protein. In contrast with in vitro studies that have suggested discrete target cell specificity of chemokines, this study showed that with the possible exception of the neutrophil chemoattractant, IL-8, no chemokine appeared to be uniquely associated with the accumulation of a specific leukocyte subset. These data implicate chemokines in the recruitment of leukocytes to lymph nodes affected by diverse disease states.
淋巴结可能是感染或恶性转化的主要靶点,并且可能呈现出与其他组织炎症中所见类似的白细胞浸润特征模式。体内白细胞向淋巴结的迁移是一个高度调控的多步骤过程,这一过程依赖于黏附分子以及尚未明确的趋化信号。趋化因子是引导白细胞亚群至炎症或免疫反应部位的精心编排的信号代码的关键部分。通过确定一系列病理性和正常人类淋巴结上趋化因子的表达,并评估每个淋巴结的细胞组成,来评估这些趋化因子在白细胞亚群选择性进入淋巴结中的潜在作用。使用趋化因子核糖探针进行原位杂交以及使用特异性抗体进行免疫组织化学,以便将趋化因子的mRNA和蛋白质表达相关联。通过使用针对独特细胞标志物的抗体对相邻切片进行免疫组织化学染色,来评估每种趋化因子的细胞来源。在病理性淋巴结中,不同细胞类型检测到巨噬细胞炎性蛋白(MIP)-1α、MIP-1β、调节激活正常T细胞表达和分泌的因子(RANTES)、巨噬细胞趋化蛋白(MCP)-1、嗜酸性粒细胞趋化因子和白细胞介素8(IL-8)有大量但各异的表达。对照淋巴结仅显示RANTES的表达,主要由高内皮微静脉表达。在所有淋巴结中,除了浸润有乳腺癌的淋巴结外,趋化因子mRNA表达与相应蛋白质高度一致。与表明趋化因子具有离散靶细胞特异性的体外研究相反,本研究表明,除了中性粒细胞趋化因子IL-8外,似乎没有趋化因子与特定白细胞亚群的积累唯一相关。这些数据表明趋化因子参与了白细胞向受多种疾病状态影响的淋巴结的募集。